{"schema_version":"secwatch.filing_event.v1","accession":"0001552781-24-000405","form_type":"8-K","ticker":"SWKHL","cik":"0001089907","company_name":"SWK Holdings Corp","filed_at":"2024-07-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:12.141205+00:00","generated_at":"2026-05-31T18:56:02.262381+00:00","sec_items":["2.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"SWK Holdings names new CFO, repurchases $1M in stock, provides portfolio updates","bullets":["Adam Rice, CPA, joined as CFO in July; Courtney Baker promoted to Controller.","Repurchased 58,567 shares for $1.0M in Q2; YTD through July 15 bought 197,969 shares for $3.4M.","Funded $2.0M term loan to AOTI in May; Journey Medical drew $5.0M additional term loan in June.","Journey Medical can draw incremental $5.0M upon FDA approval of DFD-29 (PDUFA Nov 4, 2024).","Portfolio companies AOTI, Biolase, Biotricity, Elutia, Eton, Journey, Shield reported progress."],"urls":{"canonical":"https://secwatch.observer/filing/0001552781-24-000405","json":"https://secwatch.observer/filing/0001552781-24-000405.json","markdown":"https://secwatch.observer/filing/0001552781-24-000405.md","text":"https://secwatch.observer/filing/0001552781-24-000405.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1089907/000155278124000405/0001552781-24-000405-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1089907/000155278124000405/e24312_swkh-8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-31T18:56:02.262381+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}